[4-[1-[(3-chloro-4-fluorophenyl)methyl]-5,6-dimethyl-2-piperazin-1-ylbenzimidazol-4-yl]phenyl]methanamine
C27H29ClFN5 — CID 152980151
Data last refreshed: (MolForge compound catalog, from PubChem)
About [4-[1-[(3-chloro-4-fluorophenyl)methyl]-5,6-dimethyl-2-piperazin-1-ylbenzimidazol-4-yl]phenyl]methanamine
[4-[1-[(3-chloro-4-fluorophenyl)methyl]-5,6-dimethyl-2-piperazin-1-ylbenzimidazol-4-yl]phenyl]methanamine (PubChem CID 152980151) has the molecular formula C27H29ClFN5 and a molecular weight of 478.02 g/mol. Its IUPAC name is [4-[1-[(3-chloro-4-fluorophenyl)methyl]-5,6-dimethyl-2-piperazin-1-ylbenzimidazol-4-yl]phenyl]methanamine.
Molecular Properties
| Compound Name | [4-[1-[(3-chloro-4-fluorophenyl)methyl]-5,6-dimethyl-2-piperazin-1-ylbenzimidazol-4-yl]phenyl]methanamine |
|---|---|
| PubChem CID | 152980151 |
| Molecular Formula | C27H29ClFN5 |
| Molecular Weight | 478.02 g/mol |
| Exact Mass | 477.21 |
| IUPAC Name | [4-[1-[(3-chloro-4-fluorophenyl)methyl]-5,6-dimethyl-2-piperazin-1-ylbenzimidazol-4-yl]phenyl]methanamine |
| SMILES | Cc1cc2c(nc(N3CCNCC3)n2Cc2ccc(F)c(Cl)c2)c(-c2ccc(CN)cc2)c1C |
| InChI | InChI=1S/C27H29ClFN5/c1-17-13-24-26(25(18(17)2)21-6-3-19(15-30)4-7-21)32-27(33-11-9-31-10-12-33)34(24)16-20-5-8-23(29)22(28)14-20/h3-8,13-14,31H,9-12,15-16,30H2,1-2H3 |
| InChIKey | UUFCRZILRQKUOM-UHFFFAOYSA-N |
| XLogP | 5.03 |
| TPSA | 59.11 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 478.02 |
| LogP ≤ 5 | 5.03 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 152980151 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.